Re-exploration forpostoperative bleeding (%) |
4 (3.2%) |
18 (10%) |
0.2052 (0.1047–0.4023) |
0.1847 (0.0838–0.3902) |
10-year death (%) |
6 (3.5%) |
18 (10%) |
0.3234 (0.1252–0.8352) |
0.2426(0.0808–0.7350) |
Re-operation (%) |
1 (0.6%) |
7 (3.7%) |
0.1437 (0.0175–1.1802) |
0.1078(0.0113–1.039) |
Abortion |
5 (3%) |
27 (15%) |
0.1687 (0.0634–0.4491) |
0.0702(0.0209–0.2425) |
Pregnancy free of anticoagulant complications |
141 (81%) |
101 (56%) |
3.3843 (2.0957–5.4654) |
1.4079 (0.6916–2.9513) |
Pacemaker implantation (%) |
13 (7.3%) |
14 (7.5%) |
0.9632
(0.4392–2.1124) |
1.5411 (0.7686–3.0947) |
Acute renal failure (%) |
16 (9%) |
18 (10%) |
0.8624
(0.4253–1.7491) |
0.3277 (0.1263–0.8133) |
Temporary dialysis (%) |
3 (2%) |
7 (4%) |
0.4361 (0.1109–1.7143) |
0.1657(0.0329–0.7971) |
Stroke (%) |
6 (3.5%) |
8 (4.4%) |
0.7723 (0.2624–2.2733) |
0.2935
(0.0777–1.0571) |
30-day death (%) |
1 (0.6%) |
2 (1.1%) |
0.5173 (0.0465–5.7576) |
0.3078 (0.0239–4.0534) |
Wound infection (%) |
2 (1.4%) |
3 (1.7%) |
0.6899 (0.1139–4.1799) |
0.3415 (0.0501–2.4870) |
Pericardial tamponade (%) |
11 (6.5%) |
17 (9.3%) |
0.6510
(0.2958–1.4328) |
0.4687 (0.1914–1.1391) |
Atrio-ventricular block grade III (%) |
13 (7.5%) |
16 (9%) |
0.8327
(0.3881–1.7865) |
0.4846 (0.1995–1.1577) |
Atrial fibrillation (%) |
37 (21%) |
31 (17%) |
1.3068
(0.7688–2.2212) |
0.8886 (0.4882–1.6215) |
Pneumonia (%) |
17 (9.5%) |
19 (10.5%) |
0.9232 (0.4630–1.8410) |
0.7663 (0.3602–1.6385) |
Pneumothorax (%) |
4 (2.3%) |
9 (4.7%) |
0.4497 (0.1359–1.4881) |
0.4497 (0.0906–1.8750) |
Pleural effusion (%) |
6 (3.5%) |
3 (1.4%) |
2.1190 (0.5216–8.6093) |
2.1614 (0.4940–9.2550) |